Journal
HUMAN GENOMICS
Volume 13, Issue 1, Pages -Publisher
BMC
DOI: 10.1186/s40246-019-0229-z
Keywords
Pharmacogenetics; Pharmacogenomics; PGx; Implementation of pharmacogenetics; Translation into the clinic; Clinical decision support
Categories
Funding
- European Union's Horizon 2020 research and innovation program [692145]
- Estonian Research Council [PRG184, IUT24-6]
Ask authors/readers for more resources
The field of pharmacogenomics (PGx) is gradually shifting from the reactive testing of single genes toward the proactive testing of multiple genes to improve treatment outcomes, reduce adverse events, and decrease the burden of unnecessary costs for healthcare systems. Despite the progress in the field of pharmacogenomics, its implementation into routine care has been slow due to several barriers. However, in recent years, the number of studies on the implementation of PGx has increased, all providing a wealth of knowledge on different solutions for overcoming the obstacles that have been emphasized over the past years. This review focuses on some of the challenges faced by these initiatives, the solutions and different approaches for testing that they suggest, and the evidence that they provide regarding the benefits of preemptive PGx testing.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available